The pharmaceutical industry in Germany is a robust sector characterized by innovation and a strong focus on research and development. This field comprises various entities, including multinational corporations and small biotech firms, all committed to producing medications that enhance patient care. Germany is recognized for its rigorous regulatory standards, which ensure safety and efficacy in medical products. As the demand for personalized and biologic treatments rises, German companies are increasingly shifting their focus toward innovative therapies, especially in areas like oncology and immunology, securing a competitive position in the global market.


The companies in this list cover various sizes, from large corporations to niche players, with headquarter locations ranging from Munich to Flensburg. Founded from 1907 to 2017, these firms specialize in fields such as biotechnology, generic drugs, and over-the-counter medications. Some, like MSD Sharp & Dohme GmbH and Amgen Deutschland, stand out as significant contributors due to their long histories and extensive portfolios. Together, they highlight Germany's reputation as a hub for pharmaceutical expertise and innovation.


Continue reading to discover the top pharmaceuticals companies in Germany.


Top 24 Pharmaceuticals Companies in Germany


1. MSD Sharp & Dohme GmbH

  • Website: msd.de
  • Ownership type: Private
  • Headquarters: Amt Neuhaus, Lower Saxony, Germany
  • Founded year: 2001
  • Headcount: 1001-5000
  • LinkedIn: msd-sharp-%26-dohme-gmbh

MSD Sharp & Dohme GmbH, a subsidiary of Merck & Co., Inc., is a pharmaceutical company based in Amt Neuhaus, Lower Saxony, Germany. Founded in 2001, the company specializes in the research, development, and manufacturing of innovative medications and vaccines. MSD focuses on critical therapeutic areas, particularly oncology and infectious diseases, striving to enhance health outcomes globally. The company serves healthcare providers, hospitals, and patients, emphasizing the importance of accessible healthcare solutions. With a workforce of approximately 2,438 employees, MSD is recognized as one of the largest pharmaceutical manufacturers in Germany. Their ongoing research efforts and commitment to clinical trials demonstrate their active role in advancing medical science and improving patient care.


2. Amgen Deutschland

  • Website: amgen.de
  • Ownership type: Private
  • Headquarters: Munich, Bavaria, Germany
  • Employee distribution: Germany 97%, Jordan 3%
  • Founded year: 1989
  • Headcount: 501-1000
  • LinkedIn: amgengermany

Amgen Deutschland, based in Munich, Bavaria, is a biotechnology company founded in 1989. It operates as a private entity with a workforce of approximately 501-1000 employees. The company is dedicated to developing innovative therapies aimed at treating serious diseases, with a strong emphasis on oncology and chronic inflammatory conditions. Amgen Deutschland offers a range of biopharmaceutical products and biosimilars, showcasing its expertise in the biotechnological manufacturing of medicines. The company is committed to enhancing patient outcomes through advanced medical solutions and actively engages with healthcare providers, patients, and organizations. Their research initiatives focus on understanding biological mechanisms of diseases, which is crucial for developing effective treatments. Amgen Deutschland also participates in educational programs and community engagement, reflecting its commitment to social responsibility and scientific advancement.


3. Mundipharma Germany GmbH & Co. KG


Mundipharma Germany GmbH & Co. KG, founded in 1967 and based in Frankfurt, Hesse, is a private pharmaceutical company dedicated to research and development. The company specializes in creating innovative therapeutic solutions for serious health conditions, with a strong emphasis on oncology and pain management. Mundipharma operates in various therapeutic areas, providing healthcare professionals, hospitals, and patients with essential medications. Their product portfolio includes pain management solutions, biosimilars, and treatments for respiratory diseases. Mundipharma is committed to patient-centered care, working closely with healthcare providers to enhance treatment outcomes. The company has a global presence, with operations extending across multiple continents, including Europe, Asia, and Latin America. This international reach allows them to address health challenges on a broader scale, reinforcing their role in the pharmaceutical industry.


4. SERVIER Deutschland GmbH

  • Website: servier.de
  • Ownership type: Private
  • Headquarters: Flensburg, Schleswig-Holstein, Germany
  • Employee distribution: Germany 100%
  • Founded year: 1996
  • Headcount: 201-500
  • LinkedIn: servier-deutschland

SERVIER Deutschland GmbH, founded in 1996 and based in Flensburg, Germany, is a private pharmaceutical company dedicated to developing innovative therapies for various medical conditions. The company specializes in areas such as cardiovascular diseases, cancer, and depression, focusing on patient needs and collaborating with healthcare providers to deliver effective treatment options. With a workforce of approximately 103 employees, SERVIER Deutschland is part of a larger global organization that operates in over 150 countries. The company is committed to research and development, investing more than 20% of its pharmaceutical revenues into this area. They actively participate in clinical studies and have established a presence in the German pharmaceutical market, emphasizing their role in advancing healthcare solutions. Their commitment to social responsibility and sustainability further underscores their dedication to improving patient outcomes and contributing positively to society.


5. Tiefenbacher Group


Tiefenbacher Group, founded in 1963 and based in Hamburg, Germany, is a family-owned healthcare company that specializes in the development, manufacturing, and distribution of pharmaceuticals and medical devices. The company operates along the entire pharmaceutical value chain, from sourcing raw materials to delivering finished dosage forms such as tablets, capsules, and patches. With a workforce of around 800 employees, the company emphasizes a patient-centric approach, aiming to improve access to affordable healthcare solutions worldwide. They have successfully obtained over 15,000 marketing authorizations across more than 80 countries, showcasing their capability to navigate complex regulatory environments. Their product portfolio includes over 180 finished dosage forms and a wide range of active pharmaceutical ingredients (APIs), catering to various therapeutic areas including oncology, respiratory, and infectious diseases. The company also integrates innovative medical devices with e-health solutions, enhancing treatment efficacy and patient outcomes. Their commitment to quality is reflected in their compliance with international standards, ensuring safety and reliability in their products.


6. Dermapharm Holding SE

  • Website: ir.dermapharm.de
  • Ownership type: Corporate
  • Headquarters: Flensburg, Schleswig-Holstein, Germany
  • Employee distribution: Germany 88%, Spain 12%
  • Latest funding: $495.0M, July 2022
  • Founded year: 1991
  • Headcount: 1001-5000
  • LinkedIn: dermapharm-holding-se

Dermapharm Holding SE, based in Flensburg, Germany, is a pharmaceutical manufacturer that specializes in branded medicines and health products. Established in 1991, the company has grown to employ between 1,001 and 5,000 people, with a significant portion of its workforce located in Germany and a smaller presence in Spain. Dermapharm focuses on in-house development and production, ensuring high-quality pharmaceutical solutions for healthcare professionals and organizations. The company boasts over 1,300 drug approvals and is actively engaged in more than 60 development projects, showcasing its commitment to innovation and market responsiveness. With a reported revenue of €578.5 million in the first half of 2024 and an EBITDA of €153 million, Dermapharm demonstrates strong financial health and growth potential. Their integrated business model includes a pharmaceutical sales force that enhances their market reach, making them a notable entity in the pharmaceutical sector.


7. HERMES ARZNEIMITTEL GmbH


HERMES ARZNEIMITTEL GmbH, based in Pullach, Bavaria, Germany, is a family-owned pharmaceutical company founded in 1907. The company specializes in the development, manufacturing, and marketing of health products and over-the-counter (OTC) medications. With a workforce of around 150 employees, HERMES ARZNEIMITTEL operates primarily in Germany, with a small percentage of its business in Austria. The company boasts a portfolio of over 30 successful OTC brands, generating an annual revenue exceeding 100 million euros. HERMES ARZNEIMITTEL is recognized as one of the top 15 OTC manufacturers in Germany. The company is committed to quality and customer satisfaction, ensuring that its products meet high standards of efficacy and safety. Additionally, HERMES ARZNEIMITTEL has established partnerships in approximately 30 countries, facilitating the export of its products across Europe, Asia, and South America. This international presence underscores the company's ambition to grow and adapt in the competitive pharmaceutical market.


8. TAD Pharma GmbH

  • Website: tad.de
  • Ownership type: Private
  • Headquarters: Cuxhaven, Lower Saxony, Germany
  • Employee distribution: Germany 87%, Iraq 13%
  • Founded year: 1968
  • Headcount: 201-500
  • LinkedIn: tad-pharma

TAD Pharma GmbH, based in Cuxhaven, Lower Saxony, Germany, is a pharmaceutical company that has been operational since 1968. Initially focused on veterinary products, the company expanded into human medicine shortly thereafter. TAD Pharma specializes in the production and distribution of both human and veterinary medicines, as well as medical products. It serves healthcare professionals, pharmacies, and veterinary clinics, providing essential medications for a variety of health conditions. The company is committed to maintaining high standards in its manufacturing processes, adhering to international quality guidelines. TAD Pharma is a member of the Krka Group, which enhances its capabilities and market reach. With a portfolio that includes over 120 active ingredients, TAD Pharma is recognized as a key player in the generics market, particularly in the cardiovascular and pain management sectors. The company continues to innovate and expand its offerings, ensuring its relevance in the pharmaceutical industry.


9. UCB Deutschland

  • Website: ucb.de
  • Ownership type: Private
  • Headquarters: Monheim Am Rhein, North Rhine-Westphalia, Germany
  • Employee distribution: Germany 100%
  • Founded year: 1928
  • Headcount: 501-1000
  • LinkedIn: ucb-deutschland

UCB Deutschland, based in Monheim Am Rhein, North Rhine-Westphalia, is a biopharmaceutical company that specializes in creating innovative medications for patients suffering from severe diseases. Founded in 1928, UCB Pharma GmbH has established itself as a significant player in the pharmaceutical industry, particularly in the areas of immunology and neurology. The company is dedicated to improving the quality of life for patients through extensive research and development efforts. UCB Deutschland also engages in community health initiatives, demonstrating a commitment to social responsibility. Their product portfolio includes several notable medications, and they actively participate in clinical studies to advance treatment options. The company operates entirely within Germany, employing a workforce of between 501 and 1000 individuals, and emphasizes a sustainable business approach that prioritizes the well-being of both employees and the environment.


10. Merz Therapeutics

  • Website: merztherapeutics.com
  • Ownership type: Family Owned
  • Headquarters: Frankfurt, Hesse, Germany
  • Employee distribution: Germany 43%, United States (USA) 26%, Canada 4%, Other 27%
  • Founded year: 1908
  • Headcount: 501-1000
  • LinkedIn: merz

Merz Therapeutics, based in Frankfurt, Germany, is a family-owned pharmaceutical company that has been operational since 1908. The company specializes in therapeutic innovations aimed at improving the quality of life for patients suffering from neurological disorders, liver diseases, and dermatological conditions. Their product portfolio includes treatments for Parkinson's disease, multiple sclerosis, and other serious health issues. Merz Therapeutics emphasizes a patient-centric approach, actively engaging with patient organizations and developing services that complement their medications. With a workforce of approximately 1,199 employees, the company operates in multiple countries, including significant markets in Germany and the United States. Their commitment to research and development is evident in their ongoing efforts to expand their therapeutic offerings and improve existing treatments, ensuring they remain relevant in the pharmaceutical industry.


11. AiCuris Anti-infective Cures AG

  • Website: aicuris.com
  • Ownership type: Venture Capital
  • Headquarters: Wuppertal, North Rhine-Westphalia, Germany
  • Employee distribution: Germany 91%, France 3%, United Kingdom (UK) 3%, Other 3%
  • Latest funding: Series B, $74.8M, April 2010
  • Founded year: 2006
  • Headcount: 51-200
  • LinkedIn: aicuris-gmbh-%26-co--kg

AiCuris Anti-infective Cures AG, founded in 2006 and based in Wuppertal, Germany, is a biotechnology firm dedicated to developing antiviral therapies for patients with compromised immune systems. The company is particularly focused on addressing the medical needs of individuals who are at risk of severe infections due to conditions like cancer, AIDS, and organ transplants. Their flagship product, PREVYMIS®, is marketed in collaboration with MSD and is designed to prevent cytomegalovirus (CMV) infections in high-risk transplant recipients. Additionally, AiCuris is advancing its pipeline with pritelivir, a candidate aimed at treating resistant herpes simplex virus (HSV) infections, currently in Phase 3 trials. The company has also initiated clinical development for AIC468, targeting BK virus infections in kidney transplant patients. With a workforce of around 69 employees and a history of significant funding, AiCuris is positioned to make meaningful contributions to antiviral treatment options in the healthcare sector.


12. betapharm Arzneimittel GmbH

  • Website: betapharm.de
  • Ownership type: Corporate
  • Headquarters: Augsburg, Bavaria, Germany
  • Employee distribution: Germany 100%
  • Latest funding: $577.4M, March 2006
  • Founded year: 1993
  • Headcount: 10001+
  • LinkedIn: betapharm-arzneimittel-gmbh

betapharm Arzneimittel GmbH, established in 1993 and located in Augsburg, Bavaria, is a pharmaceutical company that specializes in the production and distribution of generic medications. The company primarily serves pharmacies and healthcare professionals, providing a range of affordable and high-quality pharmaceutical products. With a focus on enhancing patient care, betapharm is dedicated to making medications accessible to a broader population. They offer over 150 active ingredients in more than 900 dosage forms, covering various medical needs, including cardiovascular, neurological, and pain management. Since becoming part of the international Dr. Reddy’s Laboratories group in 2006, betapharm has strengthened its position in the market, leveraging the resources and expertise of a larger pharmaceutical entity. Their commitment to corporate social responsibility and transparency further underscores their role in the healthcare sector.


13. PUREN Pharma GmbH & Co. KG

  • Website: puren-pharma.de
  • Ownership type: Private
  • Headquarters: Flensburg, Schleswig-Holstein, Germany
  • Employee distribution: Germany 100%
  • Founded year: 1982
  • Headcount: 51-200
  • LinkedIn: puren-pharma

PUREN Pharma GmbH & Co. KG, founded in 1982 and based in Flensburg, Germany, is a private pharmaceutical company dedicated to the development and production of medications aimed at patients with rare and severe diseases. The company offers a range of pharmaceutical products, including antibiotics and health supplements, catering to healthcare professionals and patients in need of effective treatments. With a workforce of approximately 65 employees, PUREN Pharma emphasizes quality and innovation in its offerings. They are particularly focused on areas such as oncology and neurology, working closely with experts and scientists globally to enhance patient care. As a subsidiary of Aurobindo Pharma Ltd., PUREN Pharma benefits from a broader network while maintaining its commitment to improving health outcomes. Their active engagement in the pharmaceutical market underscores their relevance and importance in addressing critical health challenges.


14. Alfa Pharma GmbH

  • Website: alfapharma.eu
  • Ownership type: Family Owned
  • Headquarters: Heppenheim, Hesse, Germany
  • Founded year: 2014
  • Headcount: 11-50
  • LinkedIn: mpsv-pharma

Alfa Pharma GmbH, founded in 2014 and based in Heppenheim, Hesse, Germany, is a family-owned pharmaceutical and nutraceutical company. The firm specializes in the development and sale of innovative and generic products, addressing various health needs through its offerings. Alfa Pharma caters to healthcare providers, pharmacies, and consumers, providing a range of pharmaceuticals, medical devices, and nutraceuticals. The company emphasizes responsible innovation and quality management, which are critical in maintaining standards in the pharmaceutical industry. Alfa Pharma operates primarily within the European Union and emerging markets, showcasing its strategic focus on regions with growth potential. Its product portfolio includes generic drugs, medical devices, and nutraceuticals, indicating a broad approach to health solutions. The company also engages in contract development and manufacturing, further solidifying its role in the pharmaceutical supply chain.


15. Bayer UK

  • Website: bayer.co.uk
  • Ownership type: Private
  • Headquarters: Leverkusen, North Rhine-Westphalia, Germany
  • Employee distribution: United Kingdom (UK) 95%, India 3%, Other 2%
  • Founded year: 2017
  • Headcount: 501-1000
  • LinkedIn: bayer-in-the-uk

Bayer UK, established in 2017, operates as a subsidiary of Bayer AG, a global company headquartered in Leverkusen, Germany. The firm is dedicated to healthcare and agricultural solutions, with a strong emphasis on pharmaceuticals. Bayer UK offers a range of products, particularly in the fields of radiology and oncology, catering to healthcare professionals and patients alike. Their portfolio includes advanced imaging agents like Gadovist® and Primovist®, as well as oncology treatments such as Nexavar and Stivarga. The company is committed to enhancing health and nutrition, making significant contributions to medical treatments and agricultural innovations. With a workforce primarily based in the UK, Bayer UK plays a crucial role in the local healthcare landscape, ensuring that healthcare professionals have access to effective medical solutions.


16. AET Laboratories (Subsidary of Alfred.E.Tiefenbacher, Germany)


AET Laboratories, a subsidiary of Alfred E. Tiefenbacher, is based in Hamburg, Germany, and was founded in 2003. The company specializes in the development, manufacturing, and commercialization of generic, value-added, and innovative medicines. With a workforce of approximately 224 employees, AET Laboratories operates primarily in India, where it has established its manufacturing capabilities. The company serves B2B clients in the pharmaceutical industry, focusing on high-quality healthcare solutions and e-health products aimed at enhancing patient outcomes globally. AET Laboratories has developed a robust product portfolio that includes over 180 products across various therapeutic categories, addressing a wide range of diseases. Their commitment to affordability and global availability of medicines is evident in their extensive marketing authorizations, exceeding 15,000 across more than 80 countries. This strategic positioning allows them to cater to a significant patient base, reportedly serving over 500 million patients annually.


17. Chiesi Deutschland

  • Website: chiesi.de
  • Ownership type: Private
  • Headquarters: Hamburg, Hamburg, Germany
  • Employee distribution: Germany 100%
  • Founded year: 1935
  • Headcount: 201-500
  • LinkedIn: chiesi-deutschland

Chiesi Deutschland, based in Hamburg, Germany, is a pharmaceutical company that has been in operation since 1935. The company is dedicated to the development and marketing of medications and medical devices, primarily serving healthcare providers, pharmacies, and hospitals. Chiesi Deutschland focuses on therapeutic areas such as respiratory diseases, neonatology, rare diseases, and transplantation, demonstrating a commitment to addressing critical health issues. The company emphasizes high-quality products and solutions tailored to meet the needs of its customers. As part of the Chiesi Group, which operates globally, Chiesi Deutschland plays a significant role in the pharmaceutical industry, contributing to research and development efforts and maintaining a strong presence in the market.


18. hexal.de

  • Website: hexal.de
  • Ownership type: Corporate
  • Headquarters: Radebeul, Saxony, Germany
  • Latest funding: $8.3B, February 2005
  • Founded year: 1986
  • Headcount: 5001-10000
  • LinkedIn: hexal.de

Hexal AG, based in Radebeul, Saxony, Germany, is a pharmaceutical manufacturer that specializes in generic medications. Established in 1986, the company has grown to offer an extensive range of over 5,900 medicines targeting various therapeutic areas. Hexal's commitment to providing affordable treatment options makes it a vital resource for healthcare professionals and patients alike. The company operates primarily in the pharmaceutical industry, focusing on the production and distribution of generic drugs. Hexal is recognized as a strong brand within the German healthcare system, and it is part of Sandoz, a division of Novartis, which further solidifies its position in the market. Their product offerings include both prescription and over-the-counter medications, addressing a wide array of health conditions, from chronic diseases to acute ailments.


19. bitop AG - The Ectoin Company.

  • Website: bitop.de
  • Ownership type: Family Owned
  • Headquarters: Dortmund, North Rhine-Westphalia, Germany
  • Employee distribution: Germany 95%, Egypt 5%
  • Founded year: 1993
  • Headcount: 51-200
  • LinkedIn: bitop-ag

bitop AG, known as The Ectoin Company, is a biotechnology firm based in Dortmund, Germany. Founded in 1993, the company has carved out a niche in the development and production of medical devices and products centered around Ectoin®, a natural molecule recognized for its protective properties. Their product offerings target various health issues, particularly in the areas of allergies and respiratory diseases. bitop AG operates primarily in the pharmaceutical sector, providing solutions that cater to both businesses and consumers. The company prides itself on its commitment to quality and sustainability, holding certifications such as ISO-13485 for medical devices. With a workforce of around 42 employees, bitop AG remains a family-owned entity, emphasizing long-term partnerships and scientific rigor in its operations. Their innovative products, including medEctoin®, are designed to support the body’s natural healing processes, making them relevant players in the health and wellness market.


20. Aenova Group

  • Website: aenova-group.com
  • Ownership type: Corporate
  • Headquarters: Starnberg, Bavaria, Germany
  • Employee distribution: Italy 46%, Germany 40%, Switzerland 7%, Other 7%
  • Latest funding: April 2024
  • Founded year: 2008
  • Headcount: 1001-5000
  • LinkedIn: aenova-group

Aenova Group, founded in 2008 and headquartered in Starnberg, Bavaria, Germany, is a pharmaceutical manufacturer and contract development organization. The company provides comprehensive services in pharmaceutical manufacturing, development, and packaging, catering to both pharmaceutical and healthcare companies. Aenova specializes in a variety of dosage forms, including solids, semi-solids, liquids, and sterile products. With a workforce of approximately 1,176 employees, Aenova operates 14 production sites across Europe and the USA, ensuring they can meet the needs of their clients effectively. Their services extend to the animal health sector, where they produce pharmaceuticals for both companion and farm animals. Aenova is committed to maintaining high-quality standards and has received various certifications to support their operations. They have also made significant investments in expanding their capabilities, particularly in high-potent medicines and innovative technologies, which further solidifies their position in the pharmaceutical industry.


21. Otsuka Novel Products GmbH


Otsuka Novel Products GmbH, based in Julbach, Bavaria, Germany, is a pharmaceutical company established in 2005. The firm is dedicated to developing innovative treatments for tuberculosis (TB), with a particular emphasis on multidrug-resistant TB. Their research and development efforts aim to fill critical gaps in TB treatment, addressing a global health crisis that affects millions. Otsuka Novel Products GmbH operates under the philosophy of Otsuka Pharmaceutical Co., Ltd., which emphasizes creating new products for better health worldwide. The company collaborates with healthcare professionals and organizations to ensure responsible access to their medicines, reflecting their commitment to improving health outcomes. Their work includes initiatives to curb drug resistance and enhance the quality of care in TB treatment, positioning them as a vital contributor to the pharmaceutical industry.


22. Venus Pharma GmbH

  • Website: venuspharmagmbh.de
  • Ownership type: Private
  • Headquarters: Werne, North Rhine-Westphalia, Germany
  • Employee distribution: Germany 100%
  • Founded year: 2009
  • Headcount: 51-200
  • LinkedIn: venus-pharma-gmbh

Venus Pharma GmbH, founded in 2009 and based in Werne, North Rhine-Westphalia, Germany, is a private pharmaceutical company that specializes in the manufacturing of injectable pharmaceuticals. The company focuses on critical therapeutic areas, particularly antibiotics and anticancer drugs, addressing significant health challenges faced by patients and healthcare providers. With a workforce of around 22 employees, Venus Pharma operates manufacturing facilities in Germany and India, ensuring compliance with international quality standards. Their commitment to innovation is reflected in their extensive product portfolio, which includes advanced injectables designed to meet the evolving needs of healthcare professionals. Venus Pharma has garnered recognition for its quality and timely delivery, making it a trusted partner in the pharmaceutical industry. The company has achieved over 130 marketing authorizations across 20 countries, showcasing its global reach and operational capabilities.


23. Futrue

  • Website: futrue.com
  • Ownership type: Private
  • Headquarters: Flensburg, Schleswig-Holstein, Germany
  • Employee distribution: Germany 97%, Other 3%
  • Founded year: 2008
  • Headcount: 501-1000
  • LinkedIn: futrue-gmbh

Futrue is a private healthcare company based in Flensburg, Germany, founded in 2008. The company specializes in the development and marketing of innovative pharmaceuticals and biopharmaceuticals, with a strong focus on addressing unmet medical needs. Their product portfolio includes cannabis-based therapies and probiotics, targeting both healthcare providers and consumers. Futrue operates a unique business model that emphasizes rapid innovation and market entry, allowing them to capitalize on niche markets with significant growth potential. They have established multiple pharmaceutical companies under their umbrella, such as Vertanical, which is dedicated to developing cannabis-based treatments for chronic pain. Futrue's commitment to research and development is evident in their ongoing clinical studies, including those for their lead product Ver-01, which is in Phase III trials. The company has not reported any external funding, relying instead on profits from their operational entities to support their ventures.


24. bene-Arzneimittel GmbH


bene-Arzneimittel GmbH, based in Munich, Bavaria, Germany, is a family-owned pharmaceutical company founded in 1949. The company specializes in the production and distribution of quality medications aimed at addressing various health issues. Their product lineup includes well-known medications such as ben-u-ron, which is widely used for pain and fever relief. With a workforce of approximately 67 employees, bene-Arzneimittel emphasizes high-quality manufacturing standards, with most of its products produced in Germany. The company serves healthcare professionals, pharmacies, and consumers, focusing on effective health solutions. They are also involved in research and development, continuously working on new and innovative medications to enhance patient care. Their commitment to quality and patient health has earned them trust among healthcare providers and consumers alike.



Pharmaceuticals Insights: Key Companies in Germany


CompanyHeadquarterSizeFoundedOwnership
MSD Sharp & Dohme GmbHAmt Neuhaus, Lower Saxony, Germany1001-50002001Private
Amgen DeutschlandMunich, Bavaria, Germany501-10001989Private
Mundipharma Germany GmbH & Co. KGFrankfurt, Hesse, Germany51-2001967Private
SERVIER Deutschland GmbHFlensburg, Schleswig-Holstein, Germany201-5001996Private
Tiefenbacher GroupHamburg, Hamburg, Germany501-10001963Family Owned
Dermapharm Holding SEFlensburg, Schleswig-Holstein, Germany1001-50001991Corporate
HERMES ARZNEIMITTEL GmbHPullach, Bavaria, Germany201-5001907Family Owned
TAD Pharma GmbHCuxhaven, Lower Saxony, Germany201-5001968Private
UCB DeutschlandMonheim Am Rhein, North Rhine-Westphalia, Germany501-10001928Private
Merz TherapeuticsFrankfurt, Hesse, Germany501-10001908Family Owned
AiCuris Anti-infective Cures AGWuppertal, North Rhine-Westphalia, Germany51-2002006Venture Capital
betapharm Arzneimittel GmbHAugsburg, Bavaria, Germany10001+1993Corporate
PUREN Pharma GmbH & Co. KGFlensburg, Schleswig-Holstein, Germany51-2001982Private
Alfa Pharma GmbHHeppenheim, Hesse, Germany11-502014Family Owned
Bayer UKLeverkusen, North Rhine-Westphalia, Germany501-10002017Private
AET Laboratories (Subsidary of Alfred.E.Tiefenbacher, Germany)Hamburg, Hamburg, Germany51-2002003Family Owned
Chiesi DeutschlandHamburg, Hamburg, Germany201-5001935Private
hexal.deRadebeul, Saxony, Germany5001-100001986Corporate
bitop AG - The Ectoin Company.Dortmund, North Rhine-Westphalia, Germany51-2001993Family Owned
Aenova GroupStarnberg, Bavaria, Germany1001-50002008Corporate
Otsuka Novel Products GmbHJulbach, Bavaria, Germany11-502005Private
Venus Pharma GmbHWerne, North Rhine-Westphalia, Germany51-2002009Private
FutrueFlensburg, Schleswig-Holstein, Germany501-10002008Private
bene-Arzneimittel GmbHMunich, Bavaria, Germany51-2001949Family Owned


Want to Find More Pharmaceuticals Companies?

If you want to find more companies that offer innovative medicines, patient solutions, and health products you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.

With Inven you'll also get to know the company's:

  • Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
  • Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
  • Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!